Collector’s Guide: Absol (Dragon #1)

Absol Collector’s Guide: ex3-1 from the Dragon Set

Character Intro

Absol from the Dragon set is a Rare Holo card numbered 1. With 70 HP and the attack Prize Count, this striking Basic Darkness-type adds a vivid highlight to any Dragon series lineup.

Quick Facts

set_name release_date number rarity hp illustrator
Dragon 1 Rare Holo 70 Naoyo Kimura
  • Type: Darkness
  • Stage: Basic
  • Retreat Cost: 1
  • Weakness: Fighting ×2
  • Resistance: Psychic -30
  • Attacks:
  • Bad News: Discards opponent’s cards if they have 6 or more in hand, reducing to 5.
  • Prize Count: Deals 20 damage plus 20 more if you have more Prize cards left than your opponent.

Key Printings

This exact printing is card number 1 in the Dragon set (ex3). It is a Rare Holo with no known alternate print variants. Artwork by Naoyo Kimura is distinctive and collectible.

Variants & Identifiers

No print variants or alternate artworks are documented for this card. It is uniquely identified by the set code ex3 and card number 1. The card’s market reference query is “Absol Dragon 1.”

Legality & Play Notes

  • Legality status: unknown.
  • This card is not legal in Standard, Expanded, or Unlimited formats.
  • No official tournament play notes are available.

Care & Storage Tips

To preserve the holofoil surface and vibrant artwork, store this card in a protective sleeve away from direct sunlight and moisture. Use a rigid top-loader or a binder with individual pockets to prevent bending or scratching.

Set-by-Set Micro-summaries

  • Dragon (ex3): Features Absol as a Rare Holo Basic Darkness-type Pokémon with hand disruption and damage-scaling attacks. The set’s release date is unknown, and it adds a strategic card for collectors interested in the ex series.

Absol ex3-1

Catch This Card on eBay

Search live listings for Pokemon TCG Absol Dragon.


Browse eBay listings

This section contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you.

Absol (Dragon) #1

Comments

Leave a Reply